
Results
14
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
14 companies
Lupin
Market Cap: ₹902.4b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹1,975.70
7D
-1.1%
1Y
-5.4%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹419.6b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,476.75
7D
-6.9%
1Y
-2.8%
Torrent Pharmaceuticals
Market Cap: ₹1.3t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,825.60
7D
7.0%
1Y
21.4%
Sanjivani Paranteral
Market Cap: ₹2.5b
Operates as a pharmaceutical company in India.
531569
₹204.70
7D
-3.6%
1Y
-34.8%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.1b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹211.37
7D
-2.4%
1Y
-5.9%
AstraZeneca Pharma India
Market Cap: ₹228.3b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,131.90
7D
-4.8%
1Y
23.2%
Abbott India
Market Cap: ₹627.8b
Operates as a pharmaceutical company in India.
500488
₹29,543.55
7D
0.6%
1Y
3.3%
RPG Life Sciences
Market Cap: ₹39.1b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,366.10
7D
-3.9%
1Y
4.9%
Blue Jet Healthcare
Market Cap: ₹100.5b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹579.30
7D
-4.5%
1Y
8.0%
Anlon Healthcare
Market Cap: ₹7.7b
Manufactures and sells advance pharmaceutical intermediates in India and internationally.
AHCL
₹145.75
7D
4.7%
1Y
n/a
Asston Pharmaceuticals
Market Cap: ₹643.6m
Manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries.
544445
₹75.60
7D
-8.5%
1Y
n/a
Rubicon Research
Market Cap: ₹102.3b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹620.90
7D
-4.9%
1Y
n/a
Influx Healthtech
Market Cap: ₹4.2b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹179.70
7D
-5.7%
1Y
n/a
Nirman Agri Genetics
Market Cap: ₹560.7m
Operates as an agri-input company in India.
NIRMAN
₹70.00
7D
-18.4%
1Y
-80.6%